Global Burkitt Lymphoma Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 19658

Burn is an injury to skin or any tissue of body due to excessive heat, radiation, radioactivity, electricity, or contact with chemical materials. Burns are a serious problem across the globe and the World Health Organization estimates that it results in more than 265,000 deaths occur annually. Moreover, the number of non-fatal burn incidences is very high and require serious medical attention.
For small burns, the wound closure with autologous skin can be performed but for burns greater than 50 percent total body surface area, wound closure must be achieved by using combination of autograft and allograft or synthetic wound coverings.  In case of large burns, cadaver skin have been proved to be life saving. Synthetic covers which can be used as alternatives of cadaver skin include, Biobrane (Smith & Nephew plc), Dermagraft-TC (MediLexicon International Ltd.). The global burn treatment market is driven from traditional products in categories such as anti-infective drugs and pressure-relief devices. However, the advanced therapies which reduce healing time and achieve significant cost savings will drive the future burn treatment market. Since the burn trauma continues to have a large socioeconomic impact on the healthcare, the market for burn treatment will expand as more people get access to advanced trauma care.
The advancement in the understanding of burn pathology has led to improved and better wound healing products in the market. The recent products in the market which have made significant improvements in treatment levels of burn patients include endoscopic subfascial ligation of venous perforators, endovascular arterial repair techniques, hyperbaric oxygen therapy, recombinant growth factors, and xenogeneic tissue scaffold. Biologic dressings are among these advances which have promising market in the near future and this segment of market is led by Johnson & Johnson with its brands such as Promogram and NUGEL. Another advancement in the burns treatment market include launch of ReCell (spray-on-skin product) by Avita Medical which uses patients own skin to regenerate and accelerate wound healing. These advancements in the market are increasing the survival of burn patients and therefore will continue to propel the global burn treatment market.
In 2018, the global Burkitt Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Burkitt Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Burkitt Lymphoma Therapeutics development in United States, Europe and China.

The key players covered in this study
Shire
Avita Medical
Smith&Nephew
Coloplast Group
Systagenix Wound Management
MölnlyckeHealthCare
ConvaTec
Osiris Therapeutics

Market segment by Type, the product can be split into
Advanced Dressing
Biologics
Traditional Burn Care Products
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Burkitt Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Burkitt Lymphoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Burkitt Lymphoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Burkitt Lymphoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Advanced Dressing
1.4.3 Biologics
1.4.4 Traditional Burn Care Products
1.4.5 Others
1.5 Market by Application
1.5.1 Global Burkitt Lymphoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Burkitt Lymphoma Therapeutics Market Size
2.2 Burkitt Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Burkitt Lymphoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Burkitt Lymphoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Burkitt Lymphoma Therapeutics Market Size by Manufacturers
3.1.1 Global Burkitt Lymphoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Burkitt Lymphoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Burkitt Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Burkitt Lymphoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Burkitt Lymphoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Burkitt Lymphoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Burkitt Lymphoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Burkitt Lymphoma Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Burkitt Lymphoma Therapeutics Market Size (2014-2019)
5.2 Burkitt Lymphoma Therapeutics Key Players in United States
5.3 United States Burkitt Lymphoma Therapeutics Market Size by Type
5.4 United States Burkitt Lymphoma Therapeutics Market Size by Application

6 Europe
6.1 Europe Burkitt Lymphoma Therapeutics Market Size (2014-2019)
6.2 Burkitt Lymphoma Therapeutics Key Players in Europe
6.3 Europe Burkitt Lymphoma Therapeutics Market Size by Type
6.4 Europe Burkitt Lymphoma Therapeutics Market Size by Application

7 China
7.1 China Burkitt Lymphoma Therapeutics Market Size (2014-2019)
7.2 Burkitt Lymphoma Therapeutics Key Players in China
7.3 China Burkitt Lymphoma Therapeutics Market Size by Type
7.4 China Burkitt Lymphoma Therapeutics Market Size by Application

8 Japan
8.1 Japan Burkitt Lymphoma Therapeutics Market Size (2014-2019)
8.2 Burkitt Lymphoma Therapeutics Key Players in Japan
8.3 Japan Burkitt Lymphoma Therapeutics Market Size by Type
8.4 Japan Burkitt Lymphoma Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Burkitt Lymphoma Therapeutics Market Size (2014-2019)
9.2 Burkitt Lymphoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Burkitt Lymphoma Therapeutics Market Size by Type
9.4 Southeast Asia Burkitt Lymphoma Therapeutics Market Size by Application

10 India
10.1 India Burkitt Lymphoma Therapeutics Market Size (2014-2019)
10.2 Burkitt Lymphoma Therapeutics Key Players in India
10.3 India Burkitt Lymphoma Therapeutics Market Size by Type
10.4 India Burkitt Lymphoma Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Burkitt Lymphoma Therapeutics Market Size (2014-2019)
11.2 Burkitt Lymphoma Therapeutics Key Players in Central & South America
11.3 Central & South America Burkitt Lymphoma Therapeutics Market Size by Type
11.4 Central & South America Burkitt Lymphoma Therapeutics Market Size by Application

12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Burkitt Lymphoma Therapeutics Introduction
12.1.4 Shire Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.1.5 Shire Recent Development
12.2 Avita Medical
12.2.1 Avita Medical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Burkitt Lymphoma Therapeutics Introduction
12.2.4 Avita Medical Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.2.5 Avita Medical Recent Development
12.3 Smith&Nephew
12.3.1 Smith&Nephew Company Details
12.3.2 Company Description and Business Overview
12.3.3 Burkitt Lymphoma Therapeutics Introduction
12.3.4 Smith&Nephew Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.3.5 Smith&Nephew Recent Development
12.4 Coloplast Group
12.4.1 Coloplast Group Company Details
12.4.2 Company Description and Business Overview
12.4.3 Burkitt Lymphoma Therapeutics Introduction
12.4.4 Coloplast Group Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.4.5 Coloplast Group Recent Development
12.5 Systagenix Wound Management
12.5.1 Systagenix Wound Management Company Details
12.5.2 Company Description and Business Overview
12.5.3 Burkitt Lymphoma Therapeutics Introduction
12.5.4 Systagenix Wound Management Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.5.5 Systagenix Wound Management Recent Development
12.6 MölnlyckeHealthCare
12.6.1 MölnlyckeHealthCare Company Details
12.6.2 Company Description and Business Overview
12.6.3 Burkitt Lymphoma Therapeutics Introduction
12.6.4 MölnlyckeHealthCare Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.6.5 MölnlyckeHealthCare Recent Development
12.7 ConvaTec
12.7.1 ConvaTec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Burkitt Lymphoma Therapeutics Introduction
12.7.4 ConvaTec Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.7.5 ConvaTec Recent Development
12.8 Osiris Therapeutics
12.8.1 Osiris Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Burkitt Lymphoma Therapeutics Introduction
12.8.4 Osiris Therapeutics Revenue in Burkitt Lymphoma Therapeutics Business (2014-2019)
12.8.5 Osiris Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details